Canadian Cannabis Firm Canopy Stock Falls After Q4 Earnings Fall Short: What’s Next?

Canopy Growth Corp (NASDAQ:CGC) reported on Thursday fourth-quarter 2025 sales of CA$65 million ($45.75 million), down from CA$72.8 million a year ago. The stock has fallen by 21% since the report.

Net revenue in the quarter decreased 11% year over year, primarily due to decreased net revenue in international markets for cannabis and Storz & Bickel, offset by higher Canadian cannabis net revenue

Consolidated gross margin decreased by 500 basis points to 16% in the fourth quarter of 2025. Adjusted gross margin decreased by 200 basis points year-over-year to 19%.

Operating loss from continuing operations was CA$18 million in the fourth quarter, full-year 2025, representing an improvement of 83% compared to the fourth-quarter, full year 2024, primarily driven by a reduction in operating expenses.

Also Read: Germany’s Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved

Adjusted EBITDA loss reached CA$9 million, representing a 39% improvement year-over-year, driven primarily by the realized benefit of the company’s cost savings program. 

Canada cannabis net revenue was …

Full story available on Benzinga.com

Leave a Reply

Your email address will not be published. Required fields are marked *